Preoperative CRP (−) /CEA (−) /CA19-9 (−) /non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence-Reference-Cited by-同舟云学术

Preoperative CRP (−) /CEA (−) /CA19-9 (−) /non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence

Published:2022-10-27 Issue:4 Volume:6 Page:264-273
ISSN:2432-3853
Container-title:Journal of the Anus, Rectum and Colon
language:en
Short-container-title:J Anus Rectum Colon

Author:

Ushigome Mitsunori¹,Shimada Hideaki¹,Kaneko Tomoaki¹,Miura Yasuyuki¹,Nagashima Yasuo¹,Suzuki Takayuki¹,Kagami Satoru¹,Kurihara Akiharu¹,Funahashi Kimihiko¹

Affiliation:

1. Department of Surgery, Toho University School of Medicine

Publisher

The Japan Society of Coloproctology

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jarc/6/4/6_2022-010/_pdf

Reference23 articles.

1. 1. Yang XQ, Chen C, Wang FB, et al. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Asian Pac J Cancer Prev. 2011 Jan; 12 (5): 1251-6.

2. 2. Baqar AR, Wilkins S, Staples M, et al. The role of preoperative CEA in the management of colorectal cancer: a cohort study from two cancer centres. Int J Surg. 2019 Apr; 64: 10-5.

3. 3. Ushigome M, Shimada H, Miura Y, et al. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA. Int J Clin Oncol. 2020 Apr; 25 (4): 622-32.

4. 4. Basbug M, Arikanoglu Z, Bulbuller N, et al. Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer. Hepatogastroenterology. 2011 Mar-Apr; 58 (106): 400-5.

5. 5. Shibutani M, Maeda K, Nagahara H, et al. Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer. Anticancer Res. 2014 Jul; 34 (7): 3753-8.